Reneuron Group (RENE)

 

Latest News

ReNeuron says FDA okays cryopreserved hRPC formulation

ReNeuron Group said the US FDA has approved the cryopreserved formulation of its human retinal progenitor cell (hRP...

FDA approves cryopreserved hRPC formulation

RNS Number: 4005I ReNeuron Group plc 19 June 2017 AIM: RENE 19 June 2017 ReNeuron Group plc FDA approves cryopreserved formulation of ReNeuron's retinal stem cell therapy candidate New formulation enables expansion of Company's ophthalmology programmes ReNeuron Group plc (the "Company") (AIM: RENE), a UK-based global leader in the deve...

Notification of Preliminary Results

RNS Number: 4649H ReNeuron Group plc 08 June 2017 AIM: RENE 8 June 2017 ReNeuron Group plc Notification of Preliminary Results ReNeuron Group plc (the "Company") (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, will announce its preliminary results for the year ended 31 March 2017 on Thursday 29 June 2017. A m...

ReNeuron gets favourable feedback from US FDA

ReNeuron Group said it received favourable feedback from the US FDA at the End of Phase II meeting conducted in Apr...

All News

DateHeadlineSource
19-06-17ReNeuron says FDA okays cryopreserved hRPC formulationStockMarketWire
19-06-17FDA approves cryopreserved hRPC formulationRNS
08-06-17Notification of Preliminary ResultsRNS
05-06-17ReNeuron gets favourable feedback from US FDAStockMarketWire
05-06-17Positive FDA feedback on proposed Phase III studyRNS
18-05-17ReNeuron presents positive exosome dataStockMarketWire
18-05-17Presents positive exosome data at major conferenceRNS
11-05-17ReNeuron awarded £1.8m grant from Innovate UKStockMarketWire
11-05-17Awarded major UK cell therapy manufacturing grantRNS
05-05-17Presents new exosome data at major conferenceRNS
21-04-17ReNeuron updates on ophthalmology programmesStockMarketWire
21-04-17ReNeuron updates on clinical strategy in stroke disabilityStockMarketWire
21-04-17Update on clinical strategy in stroke disabilityRNS
21-04-17Update on progress in ophthalmology programmesRNS
01-03-17Block Listing Review and Total Voting RightsRNS
15-02-17ReNeuron featured in BBC documentaryRNS
07-02-17Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
07-02-17Director Share PurchaseRNS
01-02-17ReNeuron Group to present at the Shares Spotlight Evening in Edinburgh on 15 February 2017StockMarketWire
14-12-16Director Share PurchaseRNS
05-12-16ReNeuron widens H1 pretax lossStockMarketWire
05-12-16ReNeuron reports positive results in Phase II Stroke TrialStockMarketWire
05-12-16Interim ResultsRNS
05-12-16Reports Positive Results in Phase II Stroke TrialRNS
14-11-16Notification of Interim ResultsRNS
14-10-16ReNeuron Group Plc to present at the Shares Investor Evening in London on 27th October 2016StockMarketWire
05-10-16Notification of Major Interest in SharesRNS
22-09-16Block Listing Review and Total Voting RightsRNS
06-09-16ReNeuron passes AGM resolutionsStockMarketWire
06-09-16Result of AGMRNS
06-09-16AGM Trading UpdateRNS
05-08-16Posting of Annual Report and Notice of AGMRNS
04-08-16Stroke clinical data published in The LancetRNS
22-07-16Publication of positive pre-clinical retinal dataRNS
20-07-16Directors' Interest in Shares and Share OptionsRNS
07-07-16Preliminary ResultsRNS
14-06-16Notification of Preliminary ResultsRNS
13-06-16Reuron says patient recruitment completed in stroke trial StockMarketWire
13-06-16Patient recruitment completed in stroke trialRNS
09-06-16ReNeuron pursues brain cancer with exosome platform StockMarketWire

RSS feeds

  • Editorial news feed for LSE:RENE Editorial
  • Regulatory news feed for LSE:RENE Regulatory